Furthermore, using Msr1 antagonistic ligand, NET release was significantly reduced (Fig. 8h, i), suggesting the cardinal role of Msr1 in ferritin-NETosis in patients with AOSD. This evidence concerns the gene MSR1 and adult-onset Still disease.